Patient-reported outcomes in non-small cell lung cancer: psychometric evaluation of the PROMIS PF-SF 8c and NSCLC-SAQ in two phase 3 clinical trials.

Autor: Houts CR; Vector Psychometric Group, LLC, Chapel Hill, NC, USA., Savord A; Vector Psychometric Group, LLC, Chapel Hill, NC, USA., Gardner MJ; Vector Psychometric Group, LLC, Chapel Hill, NC, USA.; Department of Psychology, Arizona State University, Tempe, AZ, USA., Mattera M; Patient-Reported Outcome Consortium, Critical Path Institute (C-Path), Tucson, AZ, USA., Peipert JD; Feinberg School of Medicine, Northwestern University, Evanston, IL, USA., Agrawal T; Janssen Global Services, LLC, Horsham, PA, USA., Baig M; Janssen Global Services, LLC, Horsham, PA, USA., Barala P; Janssen Research and Development, LLC, Spring House, PA, USA., Bauml J; Janssen Global Services, LLC, Horsham, PA, USA., Diorio B; Janssen Research and Development, Titusville, NJ, USA., Girvin A; Janssen Global Services, LLC, Horsham, PA, USA., Sermon J; Janssen Pharmaceutica NV, Beerse, Belgium., Shah S; Janssen Research and Development, LLC, Spring House, PA, USA., Withelder M; Janssen Research and Development, LLC, Malvern, PA, USA., Wortman-Vayn H; Janssen Global Services, LLC, Raritan, NJ, USA., Schuchard J; Janssen Global Services, LLC, Horsham, PA, USA. JSchucha@its.jnj.com.

Publikováno v: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation [Qual Life Res] 2024 Dec 05. Date of Electronic Publication: 2024 Dec 05.

1835P A prospective study to determine the prevalence of DNA repair defects in patients (pts) with advanced prostate cancer (PC)

Autor: Sandhu, S.K., Gotto, G., Vera-Badillo, F.E., Byun, S-S., Cutuli, H.J., Gomes, A.J.P.D.S., Helissey, C., Karsh, L.I., Peer, A., Preto, D.D., Pu, Y-S., Ravilla, R., Roubaud, G., Skoneczna, I.A., Kim, W., Espina, B., Withelder, M., Urtishak, K., Francis, P.S.J., Saad, F.

Publikováno v: In Annals of Oncology October 2023 34 Supplement 2:S993-S993

PCR172 Patient-Reported Outcomes in Non-Small Cell Lung Cancer: Psychometric Evaluation of the PROMIS PF-SF 8C and NSCLC-SAQ in Phase 3 Clinical Trials.

Autor: Houts, CR¹ (AUTHOR), Savord, A¹ (AUTHOR), Gardner, M¹ (AUTHOR), Mattera, M² (AUTHOR), Peipert, J³ (AUTHOR), Agrawal, T⁴ (AUTHOR), Baig, M⁴ (AUTHOR), Barala, P⁴ (AUTHOR), Bauml, J⁴ (AUTHOR), Diorio, B⁴ (AUTHOR), Girvin, A⁴ (AUTHOR), Li, T⁴ (AUTHOR), Sermon, J⁵ (AUTHOR), Shah, S⁴ (AUTHOR), Withelder, M⁴ (AUTHOR), Wortman-Vayn, H⁴ (AUTHOR), Schuchard, J⁴ (AUTHOR)

Publikováno v: Value in Health. 2024 Supplement, Vol. 27 Issue 6, pS328-S328. 1p.